StockData
Nexentis Technologies Inc. logo

Nexentis Technologies Inc. (NXTS) stock

NXTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$1.82−0.17 (-8.42%)

Close on Nov 17, 2026Market cap $2.65MP/E –Yield –

Nexentis Technologies operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Nexentis Technologies's operating cash flow for the twelve months ending Jun 30, 2026 was -$4.43M. For fiscal 2025 it was -$3.81M. The highest annual figure on record is -$506.50K in fiscal 2018.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$3.81M–
FY2024Dec 31, 2024-$3.42M–
FY2023Dec 31, 2023-$3.23M–
FY2022Dec 31, 2022-$5.10M–
FY2021Dec 31, 2021-$4.11M–
FY2020Dec 31, 2020-$798.74K–
FY2019Dec 31, 2019-$1.24M–
FY2018Dec 31, 2018-$506.50K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$539.00K–
Q1 FY2026Mar 31, 2026-$1.42M–
Q4 FY2025Dec 31, 2025-$1.50M–
Q3 FY2025Sep 30, 2025-$974.00K–
Q2 FY2025Jun 30, 2025-$528.00K–
Q1 FY2025Mar 31, 2025-$809.00K–
Q4 FY2024Dec 31, 2024-$492.00K–
Q3 FY2024Sep 30, 2024-$891.00K–
Q2 FY2024Jun 30, 2024-$1.03M–
Q1 FY2024Mar 31, 2024-$1.01M–
Q4 FY2023Dec 31, 2023-$975.13K–
Q3 FY2023Sep 30, 2023-$624.45K–
Q2 FY2023Jun 30, 2023-$528.63K–
Q1 FY2023Mar 31, 2023-$1.11M–
Q4 FY2022Dec 31, 2022-$970.42K–
Q3 FY2022Sep 30, 2022-$1.77M–
Q2 FY2022Jun 30, 2022-$1.27M–
Q1 FY2022Mar 31, 2022-$1.09M–
Q4 FY2021Dec 31, 2021-$923.40K–
Q3 FY2021Sep 30, 2021-$1.47M–
Q2 FY2021Jun 30, 2021-$1.63M–
Q1 FY2021Mar 31, 2021-$84.55K–
Q4 FY2020Dec 31, 2020-$179.34K–
Q3 FY2020Sep 30, 2020-$150.40K–
Q2 FY2020Jun 30, 2020-$235.36K–
Q1 FY2020Mar 31, 2020-$233.64K–
Q4 FY2019Dec 31, 2019-$364.99K–
Q3 FY2019Sep 30, 2019-$285.10K–
Q2 FY2019Jun 30, 2019-$267.78K–
Q1 FY2019Mar 31, 2019-$326.89K–

More Nexentis Technologies figures

See a number that looks wrong?